NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.
Royalty Pharma Reports First Quarter 2025 Results
Seeking Alpha / 3 minutes from now 2 Views
Comments